This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: T, COF, MSFT, LLY, CMG

NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS

Accretive Health (AH) upgraded at Goldman from Neutral to Buy. $31 price target. Stock is attractive, following a 38% selloff.

Acme Packet (APKT) numbers reduced at Goldman. Shares of APKT now seen reaching $35, according to Goldman Sachs. Estimates also cut, given slower expected revenue growth. Neutral rating.

Alaska Air (ALK) numbers raised at Citigroup. Shares of ALK now seen reaching $81. Estimates also increased leading fundamentals and attractive valuation. Buy rating.

Alaska Air estimates raised at UBS through 2012. Solid 3Q and 2012 cost guidance positive. Maintain $81 price target and Buy rating.

Alexion Pharmaceuticals (ALXN) numbers upped at Jefferies. ALXN estimates were boosted through 2012. Company is seeing higher Soliris sales and cutting costs. Hold rating and new $58 price target.

Alexion Pharmaceutical estimates, target raised at UBS. Shares of ALXN now seen reaching $70. Estimates also increased on aHUS and margins. Neutral rating.

Alliance Data Systems (ADS) upgraded to buy at TheStreet Ratings.

Altera (ALTR - Get Report) estimates, target reduced at Jefferies. ALTR estimates were cut through 2012. Inventories are falling. Buy rating and new $43 price target.

Altera estimates, target cut at UBS. Shares of ALTR now seen reaching $44.50. Estimates also lowered as weak macro slows secular growth. Buy rating.

Associated Banc-Corp (ASBC) numbers lowered at Jefferies. Shares of ASBC now seen reaching $11. Estimates also cut, given reduced net interest income expectations. Buy rating.

AT&T (T) estimates lowered at Citigroup through 2012. Reflects an elevation in dilution from a rapid adoption of Smartphones. Maintain $32 price target and Buy rating.

AutoNation (AN) estimates, target raised at Goldman. Shares of AN now seen reaching $34. Estimates also increased, given better realized operating margin. Sell rating.

AutoNation estimates lowered at UBS through 2011. Margins tailwinds end post Q3. Maintain $30 price target and Sell rating.

Baxter (BAX - Get Report) estimates, target reduced at Goldman. BAX estimates were cut through 2014. Lower sales are hurting margins. Buy rating and new $66 price target.

Blackstone (BX) estimates adjusted at Citigroup through 2012. Reflects the 3Q shortfall, but also stronger long term asset gathering outlook. Maintain $18 price target and Buy rating.

Capital One (COF - Get Report) numbers increased at Goldman through 2013. Higher revenue is driving margin expansion. Neutral rating and new $51 price target.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ALTR $49.40 5.20%
BAX $66.88 -0.40%
COF $83.53 -0.91%
CMG $617.60 -1.90%
DIS $109.80 -0.66%

Markets

DOW 17,992.53 -133.59 -0.74%
S&P 500 2,106.65 -14.14 -0.67%
NASDAQ 5,062.9770 -34.9990 -0.69%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs